Patents by Inventor Jiefang Sun

Jiefang Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148913
    Abstract: A liposomal nanocarrier delivery system for targeting an active CD44 molecule, preparation method therefor, and uses therof. The surface of the liposome is partially modified by a targeting ligand, wherein the targeting ligand is a ligand that can be specifically combined with the active CD44 molecule. The liposomal nanocarrier delivery system can be used for diagnosing, preventing, and treating vulnerable plaque or diseases related to vulnerable plaque.
    Type: Application
    Filed: December 5, 2023
    Publication date: May 9, 2024
    Inventors: Qian Ma, Jiefang Sun
  • Patent number: 11737977
    Abstract: A cerasome delivery system for targeting activated cd44 molecule, a preparation method and use thereof: a surface of a cerasome is partially modified by a targeting ligand, the targeting ligand being a ligand which may specifically bind to an activated cd44 molecule. The cerasome delivery system may be used for the diagnosis, prevention and treatment of vulnerable plaque or diseases associated with vulnerable plaque.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: August 29, 2023
    Assignee: Beijing Inno Medicine Co., Ltd.
    Inventors: Qian Ma, Jiefang Sun
  • Patent number: 11391711
    Abstract: The present disclosure discloses a gold/quantum dot nanoprobe for detecting active ricin in a complex matrix and application thereof. The gold/quantum dot nanoprobe is a nanoprobe formed by utilizing gold nanoparticles and quantum dots, which are modified by single strand oligodeoxynucleotides (ssODN), to form double strand oligodeoxynucleotides in a base pairing hybridizing mode and assembling the gold nanoparticles and the quantum dots into a core-satellite structure. According to the present disclosure, the gold/quantum dot nanoprobe is used for detecting the active ricin, has a limit of detection of 7.46 ng/mL, is high in accuracy and good in reliability, and does not require large-scale equipment and complex operations. In order to further eliminate the false positive result, the present disclosure further provides a method for enriching ricin in a complex sample by utilizing magnetic beads.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: July 19, 2022
    Assignee: BEIJING CENTER FOR DISEASE PREVENTION AND CONTROL
    Inventors: Bing Shao, Jiefang Sun, Jing Zhang
  • Publication number: 20220137020
    Abstract: The present disclosure discloses a gold/quantum dot nanoprobe for detecting active ricin in a complex matrix and application thereof. The gold/quantum dot nanoprobe is a nanoprobe formed by utilizing gold nanoparticles and quantum dots, which are modified by single strand oligodeoxynucleotides (ssODN), to form double strand oligodeoxynucleotides in a base pairing hybridizing mode and assembling the gold nanoparticles and the quantum dots into a core-satellite structure. According to the present disclosure, the gold/quantum dot nanoprobe is used for detecting the active ricin, has a limit of detection of 7.46 ng/mL, is high in accuracy and good in reliability, and does not require large-scale equipment and complex operations. In order to further eliminate the false positive result, the present disclosure further provides a method for enriching ricin in a complex sample by utilizing magnetic beads.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 5, 2022
    Inventors: Jiefang SUN, Bing SHAO, Jing ZHANG
  • Publication number: 20210145747
    Abstract: A cerasome delivery system for targeting activated cd44 molecule, a preparation method and use thereof: a surface of a cerasome is partially modified by a targeting ligand, the targeting ligand being a ligand which may specifically bind to an activated cd44 molecule. The cerasome delivery system may be used for the diagnosis, prevention and treatment of vulnerable plaque or diseases associated with vulnerable plaque.
    Type: Application
    Filed: April 12, 2018
    Publication date: May 20, 2021
    Applicant: Beijing Inno Medicine Co., Ltd.
    Inventors: Qian Ma, Jiefang Sun
  • Publication number: 20200397926
    Abstract: A liposomal nanocarrier delivery system for targeting an active CD44 molecule, preparation method therefor, and uses thereof. The surface of the liposome is partially modified by a targeting ligand, wherein the targeting ligand is a ligand that can be specifically combined with the active CD44 molecule. The liposomal nanocarrier delivery system can be used for diagnosing, preventing, and treating vulnerable plaque or diseases related to vulnerable plaque.
    Type: Application
    Filed: January 21, 2019
    Publication date: December 24, 2020
    Inventors: Qian Ma, Jiefang Sun